News
Latest
-
![Digital illustration of a DNA double helix strand with glowing blue and red particles against a dark background.]()
Clinical Thought Leadership
-
![Digital wall of multimedia screens with news and technology content]()
Press Releases
-
![Informative content aimed at educating the public about lung cancer, early detection methods, the importance of biomarkers, and general health tips related to cancer prevention and care.]()
Educational Articles
-
![Detailed scientific studies and findings related to lung cancer detection, biomarker research, and other relevant medical research conducted or published by Cizzle Bio or related entities.]()
Research Papers
Cizzle Bio News
Stay informed with the latest updates on Cizzle Bio's milestones, industry news, and significant events. Here, you will find:
-
![Business professionals reviewing company milestones and progress reports in lung cancer diagnostics, highlighting key achievements in medical innovation.]()
Company Milestones
Discover our key achievements and progress in developing cutting-edge lung cancer diagnostics.
-
![Digital collage of news screens showcasing the latest trends and advancements in the biotechnology field, highlighting industry news and updates.]()
Industry News
Keep up with the latest trends and advancements in the biotechnology field.
-
![Doctor and business professional shaking hands, symbolizing strategic partnerships and collaborations to enhance cancer detection efforts.]()
Collaborations and Partnerships
Learn about our strategic partnerships and collaborative efforts to enhance cancer detection.
-
![Doctor presenting at a conference, discussing significant events and advancements in healthcare and biotechnology, highlighting Cizzle Bio's impact.]()
Significant Events
Get insights into important events and conferences that highlight our impact on healthcare and biotechnology.
Revolutionizing Gastric Cancer Detection: Introducing Cizzle Bio’s New Blood Test
Cizzle Bio’s new DEX-G2 test offers a non-invasive, highly accurate solution for early gastric cancer detection. Designed to empower patients and clinicians, DEX-G2 is the latest innovation in our mission to detect cancer early and save lives.
For the first time, 70% of people diagnosed with cancer in the U.S. now survive at least five years. Here’s what’s driving the progress, and why earlier detection remains critical.